Work

Real World Outcomes of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program with Commercial Lifileucel.

Year: 2026

Type: article

Study design: Observational Study

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.12.248

Authors: Amrita Desai, Cristian D Valenzuela, Matthew Blackburn, Aimee Kohn, Kevin Christmas, Staci Williamson, Rebekah J Knight, Jacqueline Trussell, Cheryl Stomberg, Rachel Bixler, Bashi Ratterree, John Vetto, Richard T Maziarz

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127368561

FWCI: 2.98

Cites:

Cited by: 1

Related to: 10